Clinical Trials Browser

Phase 1/2 × Anatomic Stage IV Breast Cancer AJCC v8 × Clear all

NCT05198843 2025-10-03

Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body

Phase 1/2 Terminated

1 enrolled 5 charts

Anatomic Stage IV Breast Cancer AJCC v8

NCT06026657 2025-07-08

Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer

Phase 1/2 Recruiting

Anatomic Stage IV Breast Cancer AJCC v8